| Serial Number | 97264106 |
| Word Mark | DETERMA RX IO TX |
| Filing Date | Friday, February 11, 2022 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, July 18, 2023 |
| Registration Number | 7110692 |
| Registration Date | Tuesday, July 18, 2023 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, May 2, 2023 |
| Description of Mark | The mark consists of the block letter wording DETERMA in blue, stacked over three leaf shape designs being squares having rounded corners at the top left and bottom right of each, and wherein the first is green with the letters "Rx" appearing in white in the center, the second is blue with the letters "IO" appearing in white in the center, and the third is red with the letters "Tx" appearing in white in the center. |
| Indication of Colors claimed | The color(s) blue, green, red, and white is/are claimed as a feature of the mark. |
| Goods and Services | Biopsy tests and devices, namely, medical instruments for use in performing biopsies and medical diagnostic apparatus for testing biomarkers; Biopsy tests and devices, namely, medical instruments for use in performing biopsies and medical diagnostic apparatus for evaluating appropriate immunotherapy cancer treatments; Cancer screening tests and devices, namely, medical devices for detecting risk factors and probability of cancer reoccurrence; Cancer screening tests and devices, namely, medical devices for evaluating immunotherapy cancer treatment options; Cancer screening tests and devices, namely, medical devices for matching cancer diagnosis with cancer treatments; Medical testing device for diagnosing cancer and detecting biological traits that effect the risk of reoccurrence; Medical diagnostic apparatus for testing a patient's response to various immunotherapy cancer treatment options in order to help determine the most effective course of treatment for that patient; Blood testing apparatus for cancer diagnosis and evaluation of treatment options; Medical testing devices for tumor diagnosis and treatment evaluation |
| Disclaimer with Predetermined Text | "RX", "IO", AND "TX" |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, February 16, 2022 |
| Primary Code | 010 |
| First Use Anywhere Date | Tuesday, November 30, 2021 |
| First Use In Commerce Date | Tuesday, November 30, 2021 |
| Party Name | Oncocyte Corporation |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Irvine, CA 92618 |
| Party Name | Oncocyte Corporation |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Irvine, CA 92618 |
| Party Name | Oncocyte Corporation |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Irvine, CA 92618 |
| Event Date | Event Description |
| Tuesday, July 18, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, July 18, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, May 2, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 2, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, April 12, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, March 30, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 15, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, March 13, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, March 13, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, December 30, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, December 30, 2022 | NON-FINAL ACTION E-MAILED |
| Friday, December 30, 2022 | NON-FINAL ACTION WRITTEN |
| Wednesday, December 7, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, December 6, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, December 6, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, July 6, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, July 6, 2022 | NON-FINAL ACTION E-MAILED |
| Wednesday, July 6, 2022 | NON-FINAL ACTION WRITTEN |
| Tuesday, June 28, 2022 | ASSIGNED TO EXAMINER |
| Thursday, February 17, 2022 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, February 16, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, February 15, 2022 | NEW APPLICATION ENTERED |